Clinical Trial Detail

NCT ID NCT02142218
Title Expanded Access Program With Nivolumab to Treat Melanoma
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

melanoma

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.